SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-100g |
Abbexa |
100 µg |
EUR 1525 |
Human IgG antibody Laboratories manufactures the cmia sars agg antibody test reagents distributed by Genprice. The Cmia Sars Agg Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Cmia products are available in stock. Specificity: Cmia Category: Sars Group: Agg Antibody
SARS-CoV-2 IgM/IgG Test Kit (Immunochromatographic Assay) |
|
EnoGene |
CE-recogniton-IVD |
EUR 350 |
|
Description: CE recogniton IVD |
SARS antibody-80R (IgG) |
|
EnoGene |
Human-,-Human-IgG1. |
EUR 276.5 |
|
Description: Human , Human IgG1. |
Human Cytomegalovirus Antibody IgG (Anti-CMV IgG) Rapid Test Kit |
|
Abbexa |
20 tests |
EUR 260.4 |
|
|
Human IgG Quick test strip |
|
EnoGene |
10 tests |
EUR 150 |
|
|
Human IgG Quick test strip |
|
MyBiosource |
5x10Tests |
EUR 1180 |
COX (Coxsackievirus Antibody IgG) ELISA test |
|
Biobase |
96T/Box |
Ask for price |
|
|
|
Description: ELISA based test for quantitative detection of COX (Coxsackievirus Antibody IgG) |
Monoclonal antibody to human IgG for rapid test |
|
MyBiosource |
1mg |
EUR 480 |
Monoclonal antibody to human IgG for rapid test |
|
MyBiosource |
2mg |
EUR 700 |
Monoclonal antibody to human IgG for rapid test |
|
MyBiosource |
5mg |
EUR 1505 |
SARS-CoV-2-Spike Antibody Rapid Test Kit |
|
Abbexa |
100 µl |
EUR 650 |
Agg Antibody information
SARS-CoV-2 Antigen Rapid Test Kit |
|
abx294181-20g |
Abbexa |
20 µg |
EUR 100 |
SARS-CoV-2 Antigen Rapid Test Kit |
|
abx294181-50g |
Abbexa |
50 µg |
EUR 450 |
SARS-CoV-2 Antigen Rapid Test Kit |
|
CoV2Ag-1 |
UnScience |
1T |
EUR 9.6 |
|
|
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
SARS-CoV-2 Antigen Rapid Test Kit |
|
CoV2Ag-25 |
UnScience |
25T/kit |
EUR 42 |
|
|
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
SARS-CoV-2 Rapid Antigen Test Nasal |
|
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
|
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
anti- SARS2 antibody |
|
FNab07610 |
FN Test |
100µg |
EUR 658.5 |
|
|
|
Description: Antibody raised against SARS2 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-100g |
Abbexa |
100 µg |
EUR 1525 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-20g |
Abbexa |
20 µg |
EUR 187.5 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-50g |
Abbexa |
50 µg |
EUR 337.5 |
SARS-CoV-2 Spike Antigen Rapid Test (Uncut pad) |
|
MBS355918-10Sheets |
MyBiosource |
10Sheets |
EUR 2305 |
Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
|
BSV-COV-11711125 |
BioServUK |
25 tests |
EUR 221 |
|
Description: Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
Lysis Buffer for SARS-CoV-2 Antigen Test Development |
|
LY-14 |
ACROBIOSYSTEMS |
10ml |
EUR 991.9 |
|
|
|
Description: N/A |
SARS-CoV-2 Nucleocapsid Antigen Rapid Test (Uncut pad) |
|
MBS355915-1Sheet |
MyBiosource |
1Sheet |
EUR 450 |
SARS-CoV-2 Nucleocapsid Antigen Rapid Test (Uncut pad) |
|
MBS355915-5Sheets |
MyBiosource |
5Sheets |
EUR 1585 |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|
IOV87952 |
INVBIO |
20T/kit |
EUR 46.8 |
|
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit |
|
MBS1563057-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit |
|
MBS1560147-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2805 |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit |
|
MBS1560147-96Tests |
MyBiosource |
96Tests |
EUR 630 |
anti- CMIP antibody |
|
FNab01787 |
FN Test |
100µg |
EUR 606.3 |
|
|
|
Description: Antibody raised against CMIP |
SARS-CoV-2 & Influenza A/B Real-Time PCR Test |
|
P0189 |
CTK Biotech |
96 |
EUR 5325 |
|
|
SARS-CoV-2 IgM/IgG Test Kit (Immunochromatographic Assay) |
|
EGIVD008 |
EnoGene |
CE-recogniton-IVD |
EUR 350 |
|
Description: CE recogniton IVD |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit (N501Y) |
|
MBS1560501-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2805 |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit (N501Y) |
|
MBS1560501-96Tests |
MyBiosource |
96Tests |
EUR 630 |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit (E484K) |
|
MBS1560504-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2805 |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit (E484K) |
|
MBS1560504-96Tests |
MyBiosource |
96Tests |
EUR 630 |
SARS-CoV-2 Surrogate Virus Neutralization Test Kit (L452R, T478K) |
|
MBS1563042-96Tests |
MyBiosource |
96Tests |
EUR 630 |
